StartLife alumnus Scope Biosciences secures €2.5 million grant

Published on
March 21, 2024

Scope Biosciences, a pioneering Dutch biotech firm and StartLife alumnus, announces the award of a €2.5 million EIC Transition grant. The grant, an outcome of the successful ERC-Proof of Concept collaboration with Wageningen University & Research initiated two years ago, will propel the development of the scopeDx platform—a comprehensive solution for point-of-care diagnostics that promises extreme accuracy in an onsite setting.